ICD-9 Code 220
Benign neoplasm of ovary
Not Valid for Submission
220 is a legacy non-billable code used to specify a medical diagnosis of benign neoplasm of ovary. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
ICD-9: | 220 |
Short Description: | Benign neoplasm ovary |
Long Description: | Benign neoplasm of ovary |
Convert 220 to ICD-10
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
- D27.9 - Benign neoplasm of unspecified ovary
Code Classification
-
Neoplasms (140–239)
-
Benign neoplasms (210-229)
- 220 Benign neoplasm of ovary
-
Benign neoplasms (210-229)
Information for Medical Professionals
Index to Diseases and Injuries
References found for the code 220 in the Index of Diseases and Injuries:
- Adenocarcinoma M8140 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- in
- adenomatous
- polyposis coli M8220 3 153.9
- adenomatous
- in
- Adenofibroma M9013 0
- endometrioid M8381 0 220
- borderline malignancy M8381 1 236.2
- malignant M8381 3 183.0
- mucinous M9015 0
- unspecified site 220
- serous M9014 0
- unspecified site 220
- unspecified site 220
- endometrioid M8381 0 220
- Adenoma sessile M8140 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- Pick s tubular M8640 0
- unspecified site
- female 220
- unspecified site
- Sertoli cell M8640 0
- unspecified site
- female 220
- unspecified site
- testicular M8640 0
- unspecified site
- female 220
- unspecified site
- tubular M8211 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- Pick s M8640 0
- unspecified site
- female 220
- unspecified site
- Pick s M8640 0
- Pick s tubular M8640 0
- Adenomatosis M8220 0
- endocrine multiple M8360 1
- single specified site see Neoplasm by site uncertain behavior
- two or more specified sites 237.4
- unspecified site 237.4
- erosive of nipple M8506 0 217
- pluriendocrine see Adenomatosis endocrine
- pulmonary M8250 1 235.7
- malignant M8250 3 see Neoplasm lung malignant
- specified site see Neoplasm by site benign
- unspecified site 211.3
- endocrine multiple M8360 1
- Androblastoma M8630 1
- benign M8630 0
- unspecified site
- female 220
- unspecified site
- tubular M8640 0
- with lipid storage M8641 0
- unspecified site
- female 220
- unspecified site
- unspecified site
- female 220
- with lipid storage M8641 0
- benign M8630 0
- Arrhenoblastoma M8630 1
- benign M8630 0
- unspecified site
- female 220
- unspecified site
- benign M8630 0
- Brenner s
- tumor benign M9000 0 220
- borderline malignancy M9000 1 236.2
- malignant M9000 3 183.0
- proliferating M9000 1 236.2
- myocardial 746.85
- tumor benign M9000 0 220
- Carcinoma M8010 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- in
- adenomatous
- polyposis coli M8220 3 153.9
- adenomatous
- in
- Chondroma M9220 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm cartilage benign- juxtacortical M9221 0 see Neoplasm bone benign
- periosteal M9221 0 see Neoplasm bone benign
- Chondromatosis M9220 1 see Neoplasm cartilage uncertain behavior
- Chondromyxosarcoma M9220 3 see Neoplasm cartilage malignant
- Chondrosarcoma M9220 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm cartilage malignant- juxtacortical M9221 3 see Neoplasm bone malignant
- mesenchymal M9240 3 see Neoplasm conNEC NEC "Not elsewhere classifiable"
This abbreviation in the index represents “other specified” when a specific code is not available for a condition the index directs the coder to the “other specified” code in the tabular.tive tissue malignant
- Cyst mucus retention serous simple
- ovary ovarian twisted 620.2
- dermoid M9084 0 220
- pseudomucinous M8470 0 220
- pseudomucinous ovary M8470 0 220
- ovary ovarian twisted 620.2
- Cystadenofibroma M9013 0
- endometrioid M8381 0 220
- borderline malignancy M8381 1 236.2
- malignant M8381 3 183.0
- mucinous M9015 0
- unspecified site 220
- serous M9014 0
- unspecified site 220
- unspecified site 220
- endometrioid M8381 0 220
- Cystadenoma M8440 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- mucinous M8470 0
- papillary M8471 0
- unspecified site 220
- unspecified site 220
- papillary M8471 0
- papillary M8450 0
- mucinous M8471 0
- unspecified site 220
- pseudomucinous M8471 0
- unspecified site 220
- serous M8460 0
- unspecified site 220
- unspecified site 220
- mucinous M8471 0
- pseudomucinous M8470 0
- papillary M8471 0
- unspecified site 220
- unspecified site 220
- papillary M8471 0
- serous M8441 0
- papillary M8460 0
- unspecified site 220
- unspecified site 220
- papillary M8460 0
- mucinous M8470 0
- Cystoma M8440 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- mucinous M8470 0
- unspecified site 220
- serous M8441 0
- unspecified site 220
- mucinous M8470 0
- Disfigurement due to scar 709.2
- Enchondroma M9220 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm bone benign- multiple congenital 756.4
- Fibrochondrosarcoma M9220 3 see Neoplasm cartilage malignant
- Leydig cell
- tumor M8650 1
- benign M8650 0
- unspecified site
- female 220
- unspecified site
- benign M8650 0
- tumor M8650 1
- Leydig Sertoli cell tumor M8631 0
- unspecified site
- female 220
- unspecified site
- Liposarcoma M8850 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm conNEC NEC "Not elsewhere classifiable"
This abbreviation in the index represents “other specified” when a specific code is not available for a condition the index directs the coder to the “other specified” code in the tabular.tive tissue malignant - Luteinoma M8610 0 220
- Luteoma M8610 0 220
- Masculinovoblastoma M8670 0 220
- Myxochondrosarcoma M9220 3 see Neoplasm cartilage malignant
- nbsp
- corpus
- albicans 183.0 198.6 233.39 220 236.2 239.5
- ovary 183.0 198.6 233.39 220 236.2 239.5
- corpus
- Papilloma M8050 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- serous surface M8461 0
- unspecified site 220
- serous surface M8461 0
- Pick s
- tubular adenoma M8640 0
- unspecified site
- female 220
- unspecified site
- tubular adenoma M8640 0
- Polyposis SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Polyp- coli adenomatous M8220 0 211.3
- adenocarcinoma in M8220 3 153.9
- carcinoma in M8220 3 153.9
- familial M8220 0 211.3
- intestinal adenomatous M8220 0 211.3
- coli adenomatous M8220 0 211.3
- Pseudomucinous
- cyst ovary M8470 0 220
- Sertoli cell
- adenoma M8640 0
- unspecified site
- female 220
- unspecified site
- tumor M8640 0
- with lipid storage M8641 0
- unspecified site
- female 220
- unspecified site
- unspecified site
- female 220
- with lipid storage M8641 0
- adenoma M8640 0
- Sertoli Leydig cell tumor M8631 0
- unspecified site
- female 220
- unspecified site
- Struma SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Goiter 240.9- ovarii M9090 0 220
- and carcinoid M9091 1 236.2
- malignant M9090 3 183.0
- ovarii M9090 0 220
- Teratoma solid M9080 1 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site uncertain behavior- ovary M9080 0 220
- embryonal immature or malignant M9080 3 183.0
- ovary M9080 0 220
- Thecoma M8600 0 220
- malignant M8600 3 183.0
- Tumor M8000 1 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site unspecified nature- brenner M9000 0 220
- borderline malignancy M9000 1 236.2
- malignant M9000 3 183.0
- proliferating M9000 1 236.2
- hilar cell M8660 0 220
- Leydig cell M8650 1
- benign M8650 0
- unspecified site
- female 220
- unspecified site
- benign M8650 0
- lipid cell ovary M8670 0 220
- lipoid cell ovary M8670 0 220
- Sertoli cell M8640 0
- with lipid storage M8641 0
- unspecified site
- female 220
- unspecified site
- unspecified site
- female 220
- with lipid storage M8641 0
- Sertoli Leydig cell M8631 0
- unspecified site
- female 220
- unspecified site
- theca cell M8600 0 220
- theca lutein M8610 0 220
- brenner M9000 0 220
Information for Patients
Benign Tumors
Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.
Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong. New cells form when your body does not need them, and old cells do not die when they should. These extra cells can divide without stopping and may form tumor.
Treatment often involves surgery. Benign tumors usually don't grow back.
NIH: National Cancer Institute
[Read More]
Ovarian Disorders
The ovaries are part of the female reproductive system. Women have two ovaries, one on each side of the uterus. Each ovary is about the size and shape of an almond.
The ovaries produce and store a woman's eggs. During ovulation, an ovary releases an egg. If that egg is fertilized by a sperm, a pregnancy can occur. Ovaries also make the female hormones estrogen and progesterone. When a woman goes through menopause, her ovaries stop making those hormones and releasing eggs.
Problems with the ovaries include:
- Ovarian cancer
- Ovarian cysts and polycystic ovary syndrome
- Primary ovarian insufficiency
- Ovarian torsion, a twisting of the ovary
[Read More]
ICD-9 Footnotes
General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Index of Diseases and Injuries Definitions
- And - The word "and" should be interpreted to mean either "and" or "or" when it appears in a title.
- Code also note - A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- Code first - Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- Type 2 Excludes Notes - A type 2 Excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- Includes Notes - This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- Inclusion terms - List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
- NOS "Not otherwise specified" - This abbreviation is the equivalent of unspecified.
- See - The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code.
- See Also - A "see also" instruction following a main term in the Alphabetic Index instructs that there is another main term that may also be referenced that may provide additional Alphabetic Index entries that may be useful. It is not necessary to follow the "see also" note when the original main term provides the necessary code.
- 7th Characters - Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- With - The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order.